Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. - Wikidata - awgldk - TriplyDB

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures.

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures.

http://www.wikidata.org/entity/Q30857848

about

The first draft of the endostatin interaction network Collagen VI related muscle disorders Regulation of corneal stroma extracellular matrix assembly Circulating NOS3 modulates left ventricular remodeling following reperfused myocardial infarction Macromolecular specificity of collagen fibrillogenesis: fibrils of collagens I and XI contain a heterotypic alloyed core and a collagen I sheath The structure of chondroitin B lyase complexed with glycosaminoglycan oligosaccharides unravels a calcium-dependent catalytic machinery Alterations of overused supraspinatus tendon: a possible role of glycosaminoglycans and HARP/pleiotrophin in early tendon pathology Mice lacking the extracellular matrix protein WARP develop normally but have compromised peripheral nerve structure and function The skeletal phenotype of chondroadherin deficient mice Proteome degradation in fossils: investigating the longevity of protein survival in ancient bone Exclusion of biglycan mutations in a cohort of patients with neuromuscular disorders.Soluble biglycan as a biomarker of inflammatory renal diseases.Comparative immunolocalisation of fibrillin-1 and perlecan in the human foetal, and HS-deficient hspg2 exon 3 null mutant mouse intervertebral disc.Biglycan deletion alters adiponectin expression in murine adipose tissue and 3T3-L1 adipocytes.Melanocytes from Patients Affected by Ullrich Congenital Muscular Dystrophy and Bethlem Myopathy have Dysfunctional Mitochondria That Can be Rescued with Cyclophilin Inhibitors.Changes in muscle cell metabolism and mechanotransduction are associated with myopathic phenotype in a mouse model of collagen VI deficiency.Deciphering cellular states of innate tumor drug responses.Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets.The small leucine-rich proteoglycan BGN accumulates in CADASIL and binds to NOTCH3 Quantitative proteomic analysis of eight cartilaginous tissues reveals characteristic differences as well as similarities between subgroups.Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis A biomechanical role for perlecan in the pericellular matrix of articular cartilage Proteomic analysis of Col11a1-associated protein complexes.Depth-dependent anisotropy of the micromechanical properties of the extracellular and pericellular matrices of articular cartilage evaluated via atomic force microscopy Extracellular matrix in the trabecular meshwork.Applying elastic fibre biology in vascular tissue engineering.Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointimae after vascular injury Recent advances in annular pathobiology provide insights into rim-lesion mediated intervertebral disc degeneration and potential new approaches to annular repair strategies.Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD/ML, an inherited macular degeneration.Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors.Expression profiling after retinal detachment and reattachment: a possible role for aquaporin-0.Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections.The collagen VI-related myopathies: muscle meets its matrix.Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats.Fell-Muir Lecture: Proteoglycans and more--from molecules to biology.High resistance of the mechanical properties of the chondrocyte pericellular matrix to proteoglycan digestion by chondroitinase, aggrecanase, or hyaluronidase.Molecular adhesion between cartilage extracellular matrix macromolecules.The role of ADAMTSs in arthritis Cell-matrix interactions in muscle disease.The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.

P2860

Q24338820-FAB9D727-7FE4-4897-9C4A-AFAA9EE5CAB8 Q24673264-459F94F8-1BE6-426C-910D-E3BAACB6DCD9 Q26830340-B8327D4C-D608-473E-B857-2ED9768E681E Q27311206-CE5FD42E-6521-4525-96AC-ECB1D505CE15 Q28187983-FBA23C18-8368-4B94-A523-15E082539947 Q28262767-04873325-B381-4EFC-927D-AE59BDBEBA55 Q28575492-4FB60530-BB6A-4AC4-8317-D8310E6F0D20 Q28585129-790E5A94-82C6-4D28-A6F2-2EC8C90FDBB0 Q28590020-B1A3C50A-DE40-4A0C-B77B-326C00E26931 Q28652769-E9FEBDCC-3E89-458A-AD5B-2EEE3A6B04E7 Q33865933-81716942-ED5D-428D-93CC-3CE5E089CC3C Q34160971-80CBFA47-14E6-4EE6-9178-B7691D01649D Q34458888-496D6B23-F1F4-44FC-B8C8-7829D036BFB9 Q34494135-B150E9F6-D0E0-4D99-A74E-CC8D267DC76A Q34547398-1B8509A2-ECE6-40DE-BD90-27C9F775C46C Q34599342-6524A0F1-D3F4-4826-B55D-D8BA23755F1E Q35012940-B05DE63A-61CA-4C92-B9F5-34BD543E6E9C Q35040061-87A6D816-46C5-45A9-9C6F-DFB58EC3F0FC Q35175576-D61967C8-37F8-4E6F-9CCF-E6A3992AC599 Q36003612-7BE9DFB0-59F6-4AEB-B5F4-0EA5CC91191B Q36075753-2E8494D5-BEC2-46CC-B1C6-A134C22D8A24 Q36219477-85711E48-FD12-466A-B105-AAA58D1C9AE9 Q36295434-2780A786-3526-481A-8BC9-CC7FDAF6AE84 Q36545224-68C10452-9FCA-439D-934D-2EFC7D62E781 Q36646381-94126B73-A99A-4D64-ADBF-6DC654FE3278 Q36737055-B45CD8B8-3433-4D49-AAA6-7FCD20DC3911 Q37061141-51AADE8D-F854-4836-9C47-1E718792A71B Q37201468-C47AD964-2D1C-4146-8131-F16811C5FD43 Q37380159-7BF4CFD1-5E48-4DF5-97F5-B1D8564D6096 Q37433274-C30261F7-7DE7-4756-ADD1-6617235F329B Q37472074-88C852E5-1005-4966-A9C2-1D29608BA9D3 Q37551632-CF799DFE-1D56-4EE9-877E-431584E84C21 Q37555710-C1FCE5A8-3848-459D-ACCC-29A8FCF8C6B7 Q37591215-9A56FB8F-49A7-4C84-BC42-2BAE8EEEDC79 Q37643794-86B72E1F-4269-4C34-8EDB-9BAE9E2FDB04 Q37684866-0999BE66-7B14-48A0-A459-A5A93640F0D0 Q37697044-7E035A19-23E1-4C64-A60E-174C2C77DF29 Q37825835-C9BD2C66-AD06-4B24-B712-8FEB5DF6FC53 Q37944530-AC5595C3-BC67-4EA8-BF39-EEB94023056D Q38075193-19C44DAE-5D01-4E4E-86D6-4709E12020C1

P2860

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures.

http://www.wikidata.org/entity/Q30857848

description

2002 nî lūn-bûn

@nan

2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures.

@ast

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures.

@en

type

label

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures.

@ast

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures.

@en

prefLabel

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures.

@ast

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures.

@en

P1433

Q30857848-F63E5B0E-7096-4AB1-8C09-1D2490A3C809

P1476

Q30857848-D0A76000-78F1-4855-82CA-C8E44EA57584

P2093

Q30857848-052E6C0C-7F8D-43BA-9478-F1091097896C

Q30857848-16BF25F2-6BD1-413D-B5B0-AFA408D2EE32

Q30857848-5091238C-7099-455E-B277-89DF54F3428D

Q30857848-5EA92B35-BBC9-4E4B-9108-4D5B05FAD235

Q30857848-9C1F3BA7-6380-450A-BC88-293C2F77ACA6

P2860

Q30857848-01E4D7F4-BA22-4D81-B9E6-019D64E4C400

Q30857848-10CEB894-7B2D-4F6A-A34A-FDC81680FF67

Q30857848-2BC21264-7BC5-4446-9817-9B37EE0B1871

Q30857848-2C7C0D23-1C14-41A1-A567-86907FC1B2F1

Q30857848-2E32A530-ACC9-4CC0-A068-27D03E71794F

Q30857848-34B41E92-48DC-4C4B-98CA-1370C087BBBE

Q30857848-3500A8DF-416C-4FEC-BF31-4CBF4F04A75B

Q30857848-3D2BCC26-73AF-4BE9-B048-4F66CA8BD562

Q30857848-45130B98-3328-420A-A92D-602991D6EF14

Q30857848-4CA01E38-C1E6-4E5E-ACF9-A84FBE542975

P304

Q30857848-FEF340DF-3A2C-4931-B3A4-EB22369C650E

P31

Q30857848-19B9CADA-97C2-4960-AE47-715648BD3AF6

P356

Q30857848-25FC4D3B-6DE6-4E5A-9B18-24AE3CDBBD04

P407

Q30857848-7B0C3F25-8455-4521-AEC4-D177DD82F81C

P433

Q30857848-769BE85F-71D0-4E87-989F-DDC5872F9023

P478

Q30857848-DC8860AD-F95A-4968-A65D-C87C167437C4

P577

Q30857848-80E35D5B-C5C0-4649-A5B0-BE3EC42C27B1

P698

Q30857848-F2534886-F434-4787-864D-2EA30F93C691

P356

P1433

Journal of Biological Chemistry

P1476

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures.

@en

P2093

Charlotte Wiberg

http://www.w3.org/2001/XMLSchema#string

Christina Wenglén

http://www.w3.org/2001/XMLSchema#string

Dick Heinegård

http://www.w3.org/2001/XMLSchema#string

Matthias Mörgelin

http://www.w3.org/2001/XMLSchema#string

Rupert Timpl

http://www.w3.org/2001/XMLSchema#string

P2860

Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues

Genomic analysis of metastasis reveals an essential role for RhoC

Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen

Recombinant expression and structural and binding properties of alpha 1(VI) and alpha 2(VI) chains of human collagen type VI

Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI

Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency

Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican

Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins

Matrix proteoglycans: from molecular design to cellular function

Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules

P304

49120-49126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M206891200

http://www.w3.org/2001/XMLSchema#string

P407

P433

51

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12354766

http://www.w3.org/2001/XMLSchema#string